Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.
Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT.
Science. 2015 May 8;348(6235):694-9. doi: 10.1126/science.aaa3662. Epub 2015 May 7.
Measles: is it still a threat?
Moten M, Phillips A, Saliba V, Harding N, Sibal B.
Br J Gen Pract. 2018 Sep;68(674):404-405. doi: 10.3399/bjgp18X697961. Epub 2018 Jul 2.
Measles immunometrics.
Pierson TC, Yewdell JW.
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14724-5. doi: 10.1073/pnas.1212243109. Epub 2012 Aug 30.
Measles virus persistence and its consequences.
Griffin DE.
Curr Opin Virol. 2020 Apr;41:46-51. doi: 10.1016/j.coviro.2020.03.003. Epub 2020 May 5.
Mitigating measles outbreaks in West Africa post-Ebola.
Truelove SA, Moss WJ, Lessler J.
Expert Rev Anti Infect Ther. 2015;13(11):1299-301. doi: 10.1586/14787210.2015.1085305. Epub 2015 Sep 7.
Measles is Back - Considerations for laboratory diagnosis.
Dunn JJ, Baldanti F, Puchhammer E, Panning M, Perez O, Harvala H; Pan American Society for Clinical Virology (PASCV) Clinical Practice and Public Policy Committee and the European Society for Clinical Virology (ESCV) Executive Committee.
J Clin Virol. 2020 Jul;128:104430. doi: 10.1016/j.jcv.2020.104430. Epub 2020 May 13.
Hemorrhagic complications of measles.
KILIC N.
Arch Pediatr (N Y). 1958 Jun;75(6):266-8.
Measles virus-induced immunosuppression.
Schneider-Schaulies S, Schneider-Schaulies J.
Curr Top Microbiol Immunol. 2009;330:243-69. doi: 10.1007/978-3-540-70617-5_12.
Measles virus, immune control, and persistence.
Griffin DE, Lin WH, Pan CH.
FEMS Microbiol Rev. 2012 May;36(3):649-62. doi: 10.1111/j.1574-6976.2012.00330.x. Epub 2012 Mar 13.
[An update on measles].
Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V.
Rev Med Interne. 2015 May;36(5):339-45. doi: 10.1016/j.revmed.2014.10.362. Epub 2015 Jan 8.
